These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1942242

  • 1. Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor alpha.
    Tadmori W, Mondal D, Tadmori I, Prakash O.
    J Virol; 1991 Dec; 65(12):6425-9. PubMed ID: 1942242
    [Abstract] [Full Text] [Related]

  • 2. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
    Lacoste J, D'Addario M, Roulston A, Wainberg MA, Hiscott J.
    J Virol; 1990 Oct; 64(10):4726-34. PubMed ID: 2204723
    [Abstract] [Full Text] [Related]

  • 3. HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines.
    Russo FO, Patel PC, Ventura AM, Pereira CA.
    Virus Res; 1999 Oct; 64(1):87-94. PubMed ID: 10500286
    [Abstract] [Full Text] [Related]

  • 4. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [Abstract] [Full Text] [Related]

  • 5. Gene activation mediated by protein kinase C in human macrophage and teratocarcinoma cells expressing aminoglycoside phosphotransferase activity.
    Maio JJ, Brown FL.
    J Cell Physiol; 1991 Dec; 149(3):548-59. PubMed ID: 1660486
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.
    Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, Fauci AS.
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):782-5. PubMed ID: 2300561
    [Abstract] [Full Text] [Related]

  • 9. Modulation of T-cell activation through protein kinase C- or A-dependent signalling pathways synergistically increases human immunodeficiency virus long terminal repeat induction by cytomegalovirus immediate-early proteins.
    Paya CV, Virelizier JL, Michelson S.
    J Virol; 1991 Oct; 65(10):5477-84. PubMed ID: 1654449
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD8+ T cell-mediated enhancement of tumour necrosis factor-alpha (TNF-alpha) production and HIV-1 LTR-driven gene expression in human monocytic cells is pertussis toxin-sensitive.
    Copeland KF, McKay PJ, Newton J, Rosenthal KL.
    Clin Exp Immunol; 1999 Jun; 116(3):479-85. PubMed ID: 10361238
    [Abstract] [Full Text] [Related]

  • 13. Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha.
    Monté D, Groux H, Raharinivo B, Plouvier B, Dewulf J, Clavel T, Grangette C, Torpier G, Auriault C, Capron A.
    Blood; 1992 May 15; 79(10):2670-9. PubMed ID: 1586716
    [Abstract] [Full Text] [Related]

  • 14. RAW264 macrophages stably transfected with an HIV-1 LTR reporter gene provide a sensitive bioassay for analysis of signalling pathways in macrophages stimulated with lipopolysaccharide, TNF-alpha or taxol.
    Sweet MJ, Hume DA.
    J Inflamm; 1995 May 15; 45(2):126-35. PubMed ID: 7583358
    [Abstract] [Full Text] [Related]

  • 15. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat.
    Gualberto A, Baldwin AS.
    J Biol Chem; 1995 Aug 25; 270(34):19680-3. PubMed ID: 7649977
    [Abstract] [Full Text] [Related]

  • 16. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
    Okamoto M, Ono M, Baba M.
    AIDS Res Hum Retroviruses; 1998 Sep 20; 14(14):1239-45. PubMed ID: 9764907
    [Abstract] [Full Text] [Related]

  • 17. A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation.
    Chang TL, Mosoian A, Pine R, Klotman ME, Moore JP.
    J Virol; 2002 Jan 20; 76(2):569-81. PubMed ID: 11752148
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.
    J Virol; 1993 May 20; 67(5):2853-61. PubMed ID: 8386279
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
    Niikura M, Dornadula G, Zhang H, Mukhtar M, Lingxun D, Khalili K, Bagasra O, Pomerantz RJ.
    Oncogene; 1996 Jul 18; 13(2):313-22. PubMed ID: 8710370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.